Head of Regulatory Sciences and Development Strategy
@
Skyline Therapeutics (Shanghai) Co., Ltd.
5 free lookups per month.
No credit card required.
Wen Chang's Location
Shanghai, China
Wen Chang's Work
Head of Regulatory Sciences and Development Strategy @ Skyline Therapeutics (Shanghai) Co., Ltd.
Head of JAPAC Regulatory Strategy and Head of China, Global Regulatory and Safety @ Amgen
VP, N. Asia Strategy and China, Global Regulatory and Safety @ Bristol Myers Squibb
Head of Regulatory Strategy, Asia, Global Drug Regulatory Affairs @ Novartis
Head of Business Development and Drug Development, Sandoz China @ Novartis
Global Program Director, Infecious Disease, Global Drug Regualtory Affairs @ Novartis
Global Development Expert, Asia Pacific, Global Drug Regulatory and Global Pharmacology @ Novartis
Program Lead, Staff Scientist, Research Scientists III, II Global Clinical Pharmacology @ Novartis
Wen Chang's Education
University at Buffalo
Ph.D.
1986
Taipei Medical University
B.S.
1980
Wen Chang's Skills
Regulatory Affairs
Clinical Research
Business Strategy
Lifesciences
Biotechnology
Pharmaceutics
Sales Effectiveness
R&D
Infectious Diseases
FDA
Wen Chang's Summary
Wen Chang, based in Shanghai, China, is currently a Head of Regulatory Sciences and Development Strategy at Skyline Therapeutics (Shanghai) Co., Ltd., bringing experience from previous roles at Amgen, Bristol Myers Squibb and Novartis. Wen Chang holds a Ph.D. @ University at Buffalo. With a robust skill set that includes Regulatory Affairs, Clinical Research, Business Strategy, Lifesciences, Biotechnology and more, Wen Chang contributes valuable insights to the industry. Wen Chang has 3 emails on RocketReach.